IBSA Institut Biochimique SA

IBSA UK&I assumes direct commercial responsibility for ialuril in the UK and Ireland

Transition supports continuity of supply and aligns ialuril with IBSA’s expanding UK uro-gynaecology portfolio 9 April 2026 -- Watford, UK -- IBSA UK&I, the UK subsidiary of Swiss pharmaceutical company IBSA, today announces that it will assume direct responsibility for the commercialisation and distribution of ialuril in the United Kingdom and Ireland from 9 April...
Via Pian Scairolo 49 CH-6912 Lugano-Pazzallo

+41 58 360 10 00